In after-hours, the stock was up 13.67% at $1.58 ... Ligand Pharmaceuticals Inc. (LGND) has signed a license agreement with Sermonix Pharmaceuticals LLC for the development and commercialization of oral Lasofoxifene in the United …
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) has entered into a definitive merger agreement to acquire Pharmacopeia (NASDAQ: PCOP) in a deal valued up to $70 million. The transaction is structured as a stock-for-stock
There have been repeated insider purchases in CLUB since November. The stock appreciates as consumer sentiment and spending improves. 3. Ligand Pharma (LGND): Imitating the substantial insider purchases we reported paid off. The …
The MLA Amendment also amended the upfront payments to the Company of Viking capital stock. If Viking completes …
But given the growth, cash flow — LGND is currently positive — and earning’s potential at Ligand, that valuation is really darn cheap. With this biotech stock, you really are getting a glimpse at the next Amgen or Celgene before it happens.
Most companies stock price histories show random or unpredictable movements ... Symbol Company # of Reports …
SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that its previously disclosed 1-for-6 reverse stock split has become effective, and will be reflected in the share price beginning …
Ligand Pharmaceuticals Inc. LGND Ligand is expected to report after market close ... Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a …
Ligand Pharmaceuticals Inc. LGND announced it has entered into a worldwide license ... with an average beat of 20.75%. Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2017 looks to be a pivotal year …
Yahoo!10mon